“Junk DNA” may hold the key to treating tough cancers. Existing drugs exploit weaknesses in cells with gene mutations. Researchers at King’s College London have identified a promising strategy for treating certain blood cancers by repurposing existing drugs. Their approach involves targeting a part of human DNA once dismissed as irrelevant, revealing it to be [...]